WebFeb 13, 2024 · February 13, 2024 - 7:00 am. NEW YORK and SAN DIEGO, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Zentalis™ Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today … WebFeb 13, 2024 · Dr. Roth joins Zentalis from GlaxoSmithKline (GSK), where she served as Vice President, Medicine Development Leader. At GSK, she built a portfolio of CD226 Axis immune checkpoint...
2024-02-13 NDAQ:ZNTL Press Release Zentalis …
WebIris Roth’s Post Iris Roth COO, Zentalis Pharmaceuticals 2y WebHere at GSK, we unite science, technology and talent to get ahead of disease together. We are committed to doing the right thing: our ambition is to improve the lives of billions … secret benifets.com
Iris Roth Profiles Facebook
WebMar 16, 2024 · Company profile. Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. WebNov 20, 2024 · Iris Roth has been working as a Vice President, Oncology R&D at GlaxoSmithKline for 3 years. GlaxoSmithKline is part of the Pharmaceuticals industry, and … WebFeb 13, 2024 · (2024-02-13 NDAQ:ZNTL) Zentalis Pharmaceuticals Appoints Dr. Iris Roth as Chief Operating Officer. Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with ... puras pinches chivas